A phase II trial of a soy beverage for subjects without clinical disease with rising prostate-specific antigen after radical radiation for prostate cancer

Nutrition and Cancer
Winkle KwanJan Lim

Abstract

Our objective was to evaluate the tolerability and effect of a daily soy beverage in prostate cancer patients with biochemical failure after radiotherapy. Patients with rising prostate-specific antigen (PSA) after radical radiation for prostate cancer were instructed to consume 500 ml of soy beverage daily for 6 mo. Tolerability of the soy beverage and compliance were assessed. PSA doubling times before and after the consumption of soy were compared. Thirty-four subjects were enrolled; 5 withdrew before 1 mo of soy for reasons unrelated to soy consumption. All remaining 29 subjects were included in the analysis. Mean consumption of the assigned soy beverage was 93%. Mild gastrointestinal upset (38%) not affecting soy consumption was the commonest side effect. PSA showed a declining trend in 4 patients (13.8%), and there was a > 100% prolongation of PSA doubling time in 8 patients (27.6%). However, PSA doubling time also showed a 50% or more shortening in 5 patients (17.2%). In our cohort of North American subjects, 6 mo of a daily soy beverage was well tolerated and was associated with a declining trend or more than 2 times prolongation of PSA doubling time in 41% of subjects. Confirmatory studies are warranted.

References

Apr 1, 1992·European Journal of Clinical Investigation·L SchweigererT Fotsis
Nov 30, 1988·Biochemical and Biophysical Research Communications·A OkuraY Monden
May 1, 1995·Journal of the American Dietetic Association·A M HutchinsJ W Lampe
Jan 1, 1994·Nutrition and Cancer·M J MessinaS Barnes
Aug 4, 1997·The Medical Journal of Australia·F O Stephens
Nov 12, 1998·Journal of the National Cancer Institute·J R HebertJ S Hampl
May 20, 1999·Journal of the American Dietetic Association·P KirkJ Lampe
Jan 1, 2003·European Urology·Hans-Peter SchmidUNKNOWN Swiss Group for Clinical Cancer Research (SAKK)
Mar 4, 2003·The Journal of Nutrition·Johanna W Lampe
Mar 26, 2004·The Prostate·Nagi B KumarJulio Pow-Sang
Apr 17, 2004·Nutrition and Cancer·Maha HussainOmer Kucuk
Oct 23, 2004·International Journal of Cancer. Journal International Du Cancer·Ries KranseFritz H Schröder
Apr 27, 2005·International Journal of Radiation Oncology, Biology, Physics·Andrew Tom BatesChuck Paltiel
Aug 12, 2005·The Journal of Urology·Dean OrnishPeter R Carroll
Sep 20, 2005·International Journal of Radiation Oncology, Biology, Physics·Anne W M LeeW M Sze
Nov 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew K Lee, Anthony V D'Amico
Jan 18, 2006·Cancer Causes & Control : CCC·Pamela L Horn-RossKenneth Jones
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew R SmithPhilip W Kantoff
Oct 31, 2006·The Journal of Urology·Timothy J DaskivichWilliam K Oh
Apr 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Andrew LoblawUNKNOWN American Society of Clinical Oncology
Oct 11, 2007·Journal of the National Cancer Institute·Henry K TsaiPeter R Carroll
Oct 12, 2007·Nutrition and Cancer·Ulka VaishampayanOmer Kucuk

❮ Previous
Next ❯

Citations

Jul 11, 2013·JAMA : the Journal of the American Medical Association·Maarten C BoslandJoanne A Davies
Aug 9, 2012·Antioxidants & Redox Signaling·Balachandran S VinodRuby John Anto
Aug 1, 2010·Nutrients·Mark Messina, Virginia Messina
May 4, 2010·Asian Journal of Andrology·Hao WangXiao-Meng Li
Sep 6, 2011·Endocrinology and Metabolism Clinics of North America·Shuk-Mei HoYuet-Kin Leung
Jan 1, 2014·The Journal of Steroid Biochemistry and Molecular Biology·Abeer M MahmoudMaarten C Bosland
Jan 27, 2019·Molecular and Clinical Oncology·Monika Kmetová SivoňováJana Jurečeková
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Giulia D'ArrigoFrancesca Spyrakis

❮ Previous
Next ❯

Software Mentioned

PSAdt

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.